Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Manuka honey mouth rinse for people on hemodialysis with periodontitis

Official title: Therapeutic Effect of Manuka Honey Oral Rinse in Periodontitis Patients Undergoing Hemodialysis

Run by Ain Shams University · NCT06726876 · Data updated 2026-11-12

This tests whether a Manuka honey mouth rinse can improve gum disease in adults with end-stage kidney disease who are receiving hemodialysis.

More Periodontitis trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorAin Shams University
Academic / other
Locations1 site (Banhā)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedDecember 30, 2025
Study endsDecember 30, 2025
Registry record updatedDecember 31, 2025
Trial IDNCT06726876 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with end-stage renal disease on hemodialysis who have clinically diagnosed periodontitis, can provide reliable consent, and meet the study's exclusion criteria are eligible.

Probably not a fit

People who smoke, have active malignancy, autoimmune disease, a history of kidney transplant, pregnancy, known allergy to honey, or who do not have periodontitis or are not on hemodialysis are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 3 interventional study enrolls adults with end-stage renal disease on hemodialysis who have clinical periodontitis. Participants will use either a Manuka honey oral rinse or a normal saline rinse as an adjunct to standard non-surgical periodontal care, and clinical periodontal measures will be tracked over the treatment period. The protocol includes monitoring of oral health outcomes and biomarkers related to inflammation and healing, including fibroblast growth factor-21. Safety, tolerability, and changes in periodontal infection and inflammation are captured as study endpoints.

Why it matters

Potential benefit: If successful, the rinse could reduce gum inflammation and bacterial burden, improving oral health and nutritional status in dialysis patients.

How similar studies have gone: Laboratory and small clinical studies suggest Manuka honey has antimicrobial and wound-healing effects, but strong clinical evidence of benefit for periodontitis—particularly in dialysis patients—is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Both genders, aged above 18 years.
* All patients must be clinically diagnosed of ESRD undergoing hemodialysis.
* All patients must have a periodontal disease.
* Patients must be able to make reliable decision or communications.

Exclusion Criteria:

* Smoking, Alcohol.
* Patient with history of any serious illness as malignancy, who undergo kidney transplant.
* Patients with any autoimmune disease.
* Vulnerable groups such as pregnant females, prisoners, mentally and physically handicapped individuals.
* Known hypersensitivity or severe adverse effects to the treatment drugs or to any ingredient of their preparation.

Where it's running

  • Benha hospital
    Banhā, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.